Bral

基本解释

IGF-1 takes part in the pathophysiological procedure of acute cere bral infarction.
IGF-1参与了急性脑梗死的病理生理过程。
Objective To investigate neuronal DNA damage a nd the regulation of Bcl-2after cere bral ischemia and reperfusion.
目的研究脑缺血再灌注(IR)后神经元DNA损伤及Bcl-2的调控作用。
Objective To study a new thrombolytic therapy of acute cere bral infarction by combined use of urokinase(UK) and protaglandin E 1(PGE 1).
目的研究探索联合溶栓剂尿激酶 (Urokinase ,UK)和前列腺素E1(ProtaglandinE1,PGE1)对急性脑梗死患者进行静脉溶栓的临床疗效观察。
The treatment consists of hemostasis,mild dose of mannitol and cere bral cell active drug,but hyperbaric oxygenation should be used carefully.
治疗给予止血、小剂量甘露醇降颅压、脑细胞赋活剂及慎重高压氧治疗。
Methods 83 patients with type2 diabetes m ellitus (group A), 20 patients with type2 diabetes mellitus associated with cere bral infarction (group B) and 35 healthy subjects (group C) were chosen in the s tudy.
方法选取2型糖尿病患者83例(A组)、合并脑梗塞患者20例(B组)、健康对照者35例(C组)作为研究对象。